Metabolomic Study for Localized Prostate Cancer

Georgetown University

Status: Invitation-only

Conditions: Prostate Cancer

Treatments: Radiation: Radiation Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT01968538

2009-096

Details and patient eligibility

About

Prostate cancer is a common disease in men treated using surgery, radiation therapy and/or hormonal therapy. Clinical prognosis relates to stage and grade of disease. Recent advances in omic analysis may offer additional information to the physician about prognosis and radiation response. We propose to establish a protocol to incorporate omic analysis into the evaluation and treatment of patients with prostate cancer.

Enrollment: 400 estimated patients

Sex: Male

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Males who are older than 18 years old,
• with clinically localized prostate cancer
• are receiving radiation therapy

Exclusion criteria

• none

Trial design

400 participants in 2 patient groups

Prostate Cancer Patients

Description:

Prostate cancer patients who underwent radiation therapy

Treatment:

Radiation: Radiation Therapy

Healthy control

Description:

age-matched male who has no known prostate cancer